Oladosu Waliu Olatunbosun, Onwah Akpojumayenrenne Lawretta, Oladosu-Olayiwola Rashidat Oluwatosin, Ahmed Abdullahi, Osinubi Medinat Omobola, Gbotosho Olabisi Abosede, Okesina Adekunle Bashiru
Department of Chemical Pathology, Federal Medical Centre, Abeokuta, Ogun State, Nigeria.
Department of Haematology, Federal Medical Centre, Abeokuta, Ogun State, Nigeria.
Int J Appl Basic Med Res. 2020 Oct-Dec;10(4):252-255. doi: 10.4103/ijabmr.IJABMR_118_19. Epub 2020 Oct 7.
Iron overload has been established to play a role in the etiopathogenesis of Type 2 diabetes mellitus (DM) as evidenced by its high prevalence among patients with hemochromatosis and transfusion-dependent diseases. This is as a result of iron redox reaction which generates free radicals that cause peroxidation of lipid-rich pancreas, leading to reduced insulin sensitivity.
This study therefore evaluated the impact of regular blood donation, an effective method of reducing iron load, on β-islet cell functions and level of glycemic control among regular whole blood donors.
This is a cross-sectional, analytical study.
Forty-two consenting regular blood donors who had donated whole blood at least twice and not more than thrice in the last 1 year were selected as cases, while 42 age-matched individuals who have never donated blood previously were selected as controls. Samples were obtained and analyzed for fasting plasma glucose, fasting plasma insulin, serum ferritin, transferrin receptor, total iron-binding capacity (TIBC), and serum iron, while Homeostatic Model Assessment (HOMA) of insulin resistance (IR) and beta sensitivity, HOMA-IR, and HOMA-β-cell function (HOMA-β%) were calculated for both groups.
Statistical analysis was done using Microsoft Excel package and the Statistical Package for the Social Sciences (SPSS) version 20.0 (SPSS Inc., Chicago, IL, USA).
Iron studies among regular blood donors and nondonors revealed lower serum iron (37.2 ± 7.3 vs. 41.1 ± 7.9 μmol/L, = 0.180) and lower serum ferritin levels (30.2 ± 26.1 vs. 42.9 ± 38.5 ng/mL, = 0.117), which were not statistically significant, while there were higher serum transferrin receptor (155.5 ± 22.6 vs. 112.8 ± 43.4 ng/mL, < 0.001) and higher serum TIBC (42.3 ± 6.4 vs. 37.8 ± 7.4 μmol/L, < 0.05), among cases than controls. The mean HOMA-IR and HOMA-β% were also significantly better among donors than nondonors.
Regular blood donation may protect the body from the toxic effects of excessive iron store, which includes improved insulin sensitivity and glycemic control.
铁过载已被证实参与2型糖尿病(DM)的发病机制,这在血色素沉着症患者和依赖输血的疾病患者中具有较高的患病率。这是铁氧化还原反应的结果,该反应产生自由基,导致富含脂质的胰腺发生过氧化,从而降低胰岛素敏感性。
因此,本研究评估了定期献血(一种降低铁负荷的有效方法)对定期全血捐献者β胰岛细胞功能和血糖控制水平的影响。
这是一项横断面分析研究。
选择42名在过去1年中至少捐献全血2次且不超过3次的自愿定期献血者作为病例,同时选择42名年龄匹配且以前从未献血的个体作为对照。采集样本并分析空腹血糖、空腹血浆胰岛素、血清铁蛋白、转铁蛋白受体、总铁结合力(TIBC)和血清铁,同时计算两组的胰岛素抵抗(IR)和β敏感性的稳态模型评估(HOMA)、HOMA-IR和HOMA-β细胞功能(HOMA-β%)。
使用Microsoft Excel软件包和社会科学统计软件包(SPSS)20.0版(美国伊利诺伊州芝加哥市SPSS公司)进行统计分析。
定期献血者和非献血者的铁研究显示,血清铁较低(37.2±7.3对41.1±7.9μmol/L,P = 0.180)和血清铁蛋白水平较低(30.2±26.1对42.9±38.5 ng/mL,P = 0.117),差异无统计学意义,而病例组的血清转铁蛋白受体较高(155.5±22.6对112.8±43.4 ng/mL,P < 0.001)和血清TIBC较高(42.3±6.4对37.8±7.4μmol/L,P < 0.05)。献血者的平均HOMA-IR和HOMA-β%也显著优于非献血者。
定期献血可能使身体免受铁储存过多的毒性作用,包括改善胰岛素敏感性和血糖控制。